Jane Street Group LLC Sells 34,419 Shares of 908 Devices Inc. (NASDAQ:MASS)

Jane Street Group LLC trimmed its position in shares of 908 Devices Inc. (NASDAQ:MASS) by 39.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 52,039 shares of the company’s stock after selling 34,419 shares during the period. Jane Street Group LLC owned about 0.15% of 908 Devices worth $181,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Charles Schwab Investment Management Inc. raised its stake in 908 Devices by 14.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 220,477 shares of the company’s stock worth $765,000 after buying an additional 28,015 shares in the last quarter. Millennium Management LLC raised its stake in 908 Devices by 35.5% in the second quarter. Millennium Management LLC now owns 618,310 shares of the company’s stock worth $3,184,000 after buying an additional 161,922 shares in the last quarter. State Street Corp raised its stake in 908 Devices by 1.2% in the third quarter. State Street Corp now owns 479,044 shares of the company’s stock worth $1,662,000 after buying an additional 5,704 shares in the last quarter. American Century Companies Inc. raised its stake in 908 Devices by 18.6% in the second quarter. American Century Companies Inc. now owns 33,718 shares of the company’s stock worth $174,000 after buying an additional 5,295 shares in the last quarter. Finally, Squarepoint Ops LLC bought a new position in 908 Devices in the second quarter worth about $250,000. 88.06% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. Leerink Partnrs cut shares of 908 Devices from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 13th. Leerink Partners restated a “market perform” rating and issued a $4.00 price objective (down previously from $12.00) on shares of 908 Devices in a report on Wednesday, November 13th. Finally, Stifel Nicolaus cut their price objective on shares of 908 Devices from $17.00 to $6.00 and set a “buy” rating on the stock in a report on Wednesday, November 13th.

908 Devices Stock Down 11.1 %

NASDAQ:MASS opened at $2.01 on Tuesday. The company’s 50 day moving average price is $2.44 and its 200-day moving average price is $3.56. 908 Devices Inc. has a 52 week low of $1.81 and a 52 week high of $8.50. The stock has a market cap of $69.99 million, a price-to-earnings ratio of -1.14 and a beta of 0.96.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.